Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. (PHBI) Stock Competitors & Peer Comparison
See (PHBI) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHBI | $0.00 | +7.50% | 597.3K | N/A | N/A | N/A |
| STMH | $0.10 | +99900.00% | 125.4B | -0.05 | -$1.89 | N/A |
| THCBF | $0.02 | +2350.00% | 58.2B | -2.45 | -$0.01 | N/A |
| MKKGY | $25.04 | +0.32% | 55.3B | 17.01 | $1.48 | +1.99% |
| MKGAF | $128.13 | +2.50% | 52.8B | 16.18 | $7.51 | +1.96% |
| CHALF | $0.38 | +379900.00% | 44.2B | -4.75 | -$0.08 | N/A |
| HLNCF | $4.66 | -0.64% | 42.9B | 22.76 | $0.21 | +1.83% |
| TKPHF | $27.35 | -0.55% | 42.7B | 47.98 | $0.57 | +4.87% |
| KHRNF | $0.01 | +79900.00% | 41.7B | -0.80 | -$0.01 | N/A |
| IPSEY | $30.42 | -5.59% | 40.3B | 19.88 | $1.53 | +0.85% |
Stock Comparison
PHBI vs STMH Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, STMH has a market cap of 125.4B. Regarding current trading prices, PHBI is priced at $0.00, while STMH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas STMH's P/E ratio is -0.05. In terms of profitability, PHBI's ROE is +0.09%, compared to STMH's ROE of -2.75%. Regarding short-term risk, PHBI is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check STMH's competition here
PHBI vs THCBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, THCBF has a market cap of 58.2B. Regarding current trading prices, PHBI is priced at $0.00, while THCBF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -2.45. In terms of profitability, PHBI's ROE is +0.09%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, PHBI is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check THCBF's competition here
PHBI vs MKKGY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, MKKGY has a market cap of 55.3B. Regarding current trading prices, PHBI is priced at $0.00, while MKKGY trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 17.01. In terms of profitability, PHBI's ROE is +0.09%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, PHBI is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check MKKGY's competition here
PHBI vs MKGAF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, MKGAF has a market cap of 52.8B. Regarding current trading prices, PHBI is priced at $0.00, while MKGAF trades at $128.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 16.18. In terms of profitability, PHBI's ROE is +0.09%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, PHBI is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check MKGAF's competition here
PHBI vs CHALF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CHALF has a market cap of 44.2B. Regarding current trading prices, PHBI is priced at $0.00, while CHALF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CHALF's P/E ratio is -4.75. In terms of profitability, PHBI's ROE is +0.09%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, PHBI is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check CHALF's competition here
PHBI vs HLNCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HLNCF has a market cap of 42.9B. Regarding current trading prices, PHBI is priced at $0.00, while HLNCF trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 22.76. In terms of profitability, PHBI's ROE is +0.09%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, PHBI is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HLNCF's competition here
PHBI vs TKPHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TKPHF has a market cap of 42.7B. Regarding current trading prices, PHBI is priced at $0.00, while TKPHF trades at $27.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 47.98. In terms of profitability, PHBI's ROE is +0.09%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, PHBI is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TKPHF's competition here
PHBI vs KHRNF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, KHRNF has a market cap of 41.7B. Regarding current trading prices, PHBI is priced at $0.00, while KHRNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas KHRNF's P/E ratio is -0.80. In terms of profitability, PHBI's ROE is +0.09%, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, PHBI is less volatile compared to KHRNF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check KHRNF's competition here
PHBI vs IPSEY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, IPSEY has a market cap of 40.3B. Regarding current trading prices, PHBI is priced at $0.00, while IPSEY trades at $30.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 19.88. In terms of profitability, PHBI's ROE is +0.09%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, PHBI is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check IPSEY's competition here
PHBI vs EVRRF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, EVRRF has a market cap of 25.4B. Regarding current trading prices, PHBI is priced at $0.00, while EVRRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, PHBI's ROE is +0.09%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, PHBI is less volatile compared to EVRRF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check EVRRF's competition here
PHBI vs SDZNY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SDZNY has a market cap of 24.7B. Regarding current trading prices, PHBI is priced at $0.00, while SDZNY trades at $56.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is -2864.50. In terms of profitability, PHBI's ROE is +0.09%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, PHBI is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SDZNY's competition here
PHBI vs SRUTF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SRUTF has a market cap of 19.6B. Regarding current trading prices, PHBI is priced at $0.00, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, PHBI's ROE is +0.09%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, PHBI is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check SRUTF's competition here
PHBI vs ESALY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, PHBI is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, PHBI's ROE is +0.09%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, PHBI is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ESALY's competition here
PHBI vs TEVJF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TEVJF has a market cap of 16.7B. Regarding current trading prices, PHBI is priced at $0.00, while TEVJF trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -97.07. In terms of profitability, PHBI's ROE is +0.09%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, PHBI is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TEVJF's competition here
PHBI vs SGIOY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SGIOY has a market cap of 14.7B. Regarding current trading prices, PHBI is priced at $0.00, while SGIOY trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 12.92. In terms of profitability, PHBI's ROE is +0.09%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, PHBI is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SGIOY's competition here
PHBI vs SGIOF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SGIOF has a market cap of 14.1B. Regarding current trading prices, PHBI is priced at $0.00, while SGIOF trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, PHBI's ROE is +0.09%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, PHBI is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SGIOF's competition here
PHBI vs BIOVF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, PHBI is priced at $0.00, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 23.09. In terms of profitability, PHBI's ROE is +0.09%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, PHBI is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check BIOVF's competition here
PHBI vs IPSEF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, PHBI is priced at $0.00, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 19.18. In terms of profitability, PHBI's ROE is +0.09%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, PHBI is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check IPSEF's competition here
PHBI vs RDDTF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, RDDTF has a market cap of 9.7B. Regarding current trading prices, PHBI is priced at $0.00, while RDDTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas RDDTF's P/E ratio is -0.50. In terms of profitability, PHBI's ROE is +0.09%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, PHBI is less volatile compared to RDDTF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check RDDTF's competition here
PHBI vs SFOSF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SFOSF has a market cap of 9B. Regarding current trading prices, PHBI is priced at $0.00, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, PHBI's ROE is +0.09%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, PHBI is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SFOSF's competition here
PHBI vs NOBDF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, PHBI is priced at $0.00, while NOBDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas NOBDF's P/E ratio is N/A. In terms of profitability, PHBI's ROE is +0.09%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, PHBI is less volatile compared to NOBDF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check NOBDF's competition here
PHBI vs ESAIY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ESAIY has a market cap of 8.2B. Regarding current trading prices, PHBI is priced at $0.00, while ESAIY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 27.04. In terms of profitability, PHBI's ROE is +0.09%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, PHBI is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ESAIY's competition here
PHBI vs ESALF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ESALF has a market cap of 8.2B. Regarding current trading prices, PHBI is priced at $0.00, while ESALF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 26.13. In terms of profitability, PHBI's ROE is +0.09%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, PHBI is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ESALF's competition here
PHBI vs TRLFF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TRLFF has a market cap of 7.6B. Regarding current trading prices, PHBI is priced at $0.00, while TRLFF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TRLFF's P/E ratio is -0.37. In terms of profitability, PHBI's ROE is +0.09%, compared to TRLFF's ROE of +0.00%. Regarding short-term risk, PHBI is more volatile compared to TRLFF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TRLFF's competition here
PHBI vs GZPHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, GZPHF has a market cap of 6B. Regarding current trading prices, PHBI is priced at $0.00, while GZPHF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 10.26. In terms of profitability, PHBI's ROE is +0.09%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, PHBI is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check GZPHF's competition here
PHBI vs HKMPF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, PHBI is priced at $0.00, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, PHBI's ROE is +0.09%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, PHBI is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HKMPF's competition here
PHBI vs HKMPY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HKMPY has a market cap of 5.6B. Regarding current trading prices, PHBI is priced at $0.00, while HKMPY trades at $50.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 15.76. In terms of profitability, PHBI's ROE is +0.09%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, PHBI is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HKMPY's competition here
PHBI vs SGFEF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, PHBI is priced at $0.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 25.24. In terms of profitability, PHBI's ROE is +0.09%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, PHBI is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check SGFEF's competition here
PHBI vs HLUBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HLUBF has a market cap of 5B. Regarding current trading prices, PHBI is priced at $0.00, while HLUBF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 10.65. In terms of profitability, PHBI's ROE is +0.09%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, PHBI is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HLUBF's competition here
PHBI vs HLBBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, PHBI is priced at $0.00, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 11.96. In terms of profitability, PHBI's ROE is +0.09%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, PHBI is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HLBBF's competition here
PHBI vs APNHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, PHBI is priced at $0.00, while APNHF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 16.43. In terms of profitability, PHBI's ROE is +0.09%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, PHBI is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check APNHF's competition here
PHBI vs SMDPY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SMDPY has a market cap of 3.9B. Regarding current trading prices, PHBI is priced at $0.00, while SMDPY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 24.48. In terms of profitability, PHBI's ROE is +0.09%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, PHBI is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SMDPY's competition here
PHBI vs LVZPF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, LVZPF has a market cap of 3.9B. Regarding current trading prices, PHBI is priced at $0.00, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, PHBI's ROE is +0.09%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, PHBI is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check LVZPF's competition here
PHBI vs CHSYF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, PHBI is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, PHBI's ROE is +0.09%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, PHBI is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check CHSYF's competition here
PHBI vs ULIHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, PHBI is priced at $0.00, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, PHBI's ROE is +0.09%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, PHBI is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ULIHF's competition here
PHBI vs INVVY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, PHBI is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, PHBI's ROE is +0.09%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, PHBI is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check INVVY's competition here
PHBI vs HYPMY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, PHBI is priced at $0.00, while HYPMY trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 20.13. In terms of profitability, PHBI's ROE is +0.09%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, PHBI is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HYPMY's competition here
PHBI vs IZQVF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, PHBI is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, PHBI's ROE is +0.09%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, PHBI is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check IZQVF's competition here
PHBI vs DNPUF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, PHBI is priced at $0.00, while DNPUF trades at $7.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 17.98. In terms of profitability, PHBI's ROE is +0.09%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, PHBI is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check DNPUF's competition here
PHBI vs APNHY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, PHBI is priced at $0.00, while APNHY trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 11.41. In terms of profitability, PHBI's ROE is +0.09%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, PHBI is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check APNHY's competition here
PHBI vs WIBFF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, WIBFF has a market cap of 2.8B. Regarding current trading prices, PHBI is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, PHBI's ROE is +0.09%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, PHBI is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check WIBFF's competition here
PHBI vs HMDCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, PHBI is priced at $0.00, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, PHBI's ROE is +0.09%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, PHBI is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check HMDCF's competition here
PHBI vs HTSUF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, PHBI is priced at $0.00, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 18.44. In terms of profitability, PHBI's ROE is +0.09%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, PHBI is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check HTSUF's competition here
PHBI vs SHEZF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SHEZF has a market cap of 2.2B. Regarding current trading prices, PHBI is priced at $0.00, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, PHBI's ROE is +0.09%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, PHBI is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SHEZF's competition here
PHBI vs TSMRF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, PHBI is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 9.84. In terms of profitability, PHBI's ROE is +0.09%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, PHBI is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TSMRF's competition here
PHBI vs DMPHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, PHBI is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, PHBI's ROE is +0.09%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, PHBI is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check DMPHF's competition here
PHBI vs LBTSF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, PHBI is priced at $0.00, while LBTSF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 88.64. In terms of profitability, PHBI's ROE is +0.09%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, PHBI is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check LBTSF's competition here
PHBI vs LJUIF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, PHBI is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, PHBI's ROE is +0.09%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, PHBI is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check LJUIF's competition here
PHBI vs ARSUF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, PHBI is priced at $0.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, PHBI's ROE is +0.09%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, PHBI is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ARSUF's competition here
PHBI vs GTBIF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, GTBIF has a market cap of 1.8B. Regarding current trading prices, PHBI is priced at $0.00, while GTBIF trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 35.90. In terms of profitability, PHBI's ROE is +0.09%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, PHBI is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check GTBIF's competition here
PHBI vs NPNKF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, NPNKF has a market cap of 1.8B. Regarding current trading prices, PHBI is priced at $0.00, while NPNKF trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 8.05. In terms of profitability, PHBI's ROE is +0.09%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, PHBI is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check NPNKF's competition here
PHBI vs EVOTF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, PHBI is priced at $0.00, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -6.88. In terms of profitability, PHBI's ROE is +0.09%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, PHBI is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check EVOTF's competition here
PHBI vs YIHCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, PHBI is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, PHBI's ROE is +0.09%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, PHBI is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check YIHCF's competition here
PHBI vs MITPF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, PHBI is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, PHBI's ROE is +0.09%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, PHBI is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check MITPF's competition here
PHBI vs CASBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CASBF has a market cap of 1.6B. Regarding current trading prices, PHBI is priced at $0.00, while CASBF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -23.81. In terms of profitability, PHBI's ROE is +0.09%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, PHBI is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check CASBF's competition here
PHBI vs KARBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, PHBI is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, PHBI's ROE is +0.09%, compared to KARBF's ROE of N/A. Regarding short-term risk, PHBI is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check KARBF's competition here
PHBI vs NPPNY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, PHBI is priced at $0.00, while NPPNY trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 6.43. In terms of profitability, PHBI's ROE is +0.09%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, PHBI is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check NPPNY's competition here
PHBI vs CHIZF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, PHBI is priced at $0.00, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, PHBI's ROE is +0.09%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, PHBI is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check CHIZF's competition here
PHBI vs TWAPF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, PHBI is priced at $0.00, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, PHBI's ROE is +0.09%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, PHBI is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TWAPF's competition here
PHBI vs CURLF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CURLF has a market cap of 1.2B. Regarding current trading prices, PHBI is priced at $0.00, while CURLF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -4.91. In terms of profitability, PHBI's ROE is +0.09%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, PHBI is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check CURLF's competition here
PHBI vs GNMLF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, PHBI is priced at $0.00, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, PHBI's ROE is +0.09%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, PHBI is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check GNMLF's competition here
PHBI vs SWGHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, PHBI is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, PHBI's ROE is +0.09%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, PHBI is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SWGHF's competition here
PHBI vs SHPHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, PHBI is priced at $0.00, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, PHBI's ROE is +0.09%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, PHBI is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check SHPHF's competition here
PHBI vs TCNNF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TCNNF has a market cap of 991.7M. Regarding current trading prices, PHBI is priced at $0.00, while TCNNF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -6.57. In terms of profitability, PHBI's ROE is +0.09%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, PHBI is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check TCNNF's competition here
PHBI vs KSPHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, KSPHF has a market cap of 988.2M. Regarding current trading prices, PHBI is priced at $0.00, while KSPHF trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 12.96. In terms of profitability, PHBI's ROE is +0.09%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, PHBI is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check KSPHF's competition here
PHBI vs BIOGY Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, BIOGY has a market cap of 986M. Regarding current trading prices, PHBI is priced at $0.00, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 33.62. In terms of profitability, PHBI's ROE is +0.09%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, PHBI is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check BIOGY's competition here
PHBI vs KKPCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, KKPCF has a market cap of 980.3M. Regarding current trading prices, PHBI is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 10.71. In terms of profitability, PHBI's ROE is +0.09%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, PHBI is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check KKPCF's competition here
PHBI vs NIKA Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, NIKA has a market cap of 972.9M. Regarding current trading prices, PHBI is priced at $0.00, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, PHBI's ROE is +0.09%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, PHBI is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check NIKA's competition here
PHBI vs NRXCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, NRXCF has a market cap of 837.1M. Regarding current trading prices, PHBI is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, PHBI's ROE is +0.09%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, PHBI is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check NRXCF's competition here
PHBI vs CSWYF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, PHBI is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, PHBI's ROE is +0.09%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, PHBI is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check CSWYF's competition here
PHBI vs AGYTF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, PHBI is priced at $0.00, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, PHBI's ROE is +0.09%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, PHBI is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check AGYTF's competition here
PHBI vs ABSCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ABSCF has a market cap of 706.4M. Regarding current trading prices, PHBI is priced at $0.00, while ABSCF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, PHBI's ROE is +0.09%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, PHBI is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check ABSCF's competition here
PHBI vs TRXPF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, PHBI is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, PHBI's ROE is +0.09%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, PHBI is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TRXPF's competition here
PHBI vs LVTTF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, LVTTF has a market cap of 656.3M. Regarding current trading prices, PHBI is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, PHBI's ROE is +0.09%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, PHBI is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check LVTTF's competition here
PHBI vs BOIRF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, BOIRF has a market cap of 622.4M. Regarding current trading prices, PHBI is priced at $0.00, while BOIRF trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 25.25. In terms of profitability, PHBI's ROE is +0.09%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, PHBI is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check BOIRF's competition here
PHBI vs TRSSF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, PHBI is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, PHBI's ROE is +0.09%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, PHBI is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check TRSSF's competition here
PHBI vs SWDCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, SWDCF has a market cap of 580.2M. Regarding current trading prices, PHBI is priced at $0.00, while SWDCF trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 90.75. In terms of profitability, PHBI's ROE is +0.09%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, PHBI is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check SWDCF's competition here
PHBI vs MNFSF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, PHBI is priced at $0.00, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, PHBI's ROE is +0.09%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, PHBI is less volatile compared to MNFSF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check MNFSF's competition here
PHBI vs AIHLF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, AIHLF has a market cap of 543.1M. Regarding current trading prices, PHBI is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, PHBI's ROE is +0.09%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, PHBI is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check AIHLF's competition here
PHBI vs ELTP Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ELTP has a market cap of 532.2M. Regarding current trading prices, PHBI is priced at $0.00, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -24.85. In terms of profitability, PHBI's ROE is +0.09%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, PHBI is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ELTP's competition here
PHBI vs CCHWF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, PHBI is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, PHBI's ROE is +0.09%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, PHBI is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check CCHWF's competition here
PHBI vs PEXXF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, PHBI is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, PHBI's ROE is +0.09%, compared to PEXXF's ROE of N/A. Regarding short-term risk, PHBI is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check PEXXF's competition here
PHBI vs KHTRF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, KHTRF has a market cap of 448.4M. Regarding current trading prices, PHBI is priced at $0.00, while KHTRF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 64.29. In terms of profitability, PHBI's ROE is +0.09%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, PHBI is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check KHTRF's competition here
PHBI vs HUMDF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, PHBI is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, PHBI's ROE is +0.09%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, PHBI is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check HUMDF's competition here
PHBI vs LRDSF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, LRDSF has a market cap of 376.8M. Regarding current trading prices, PHBI is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, PHBI's ROE is +0.09%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, PHBI is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check LRDSF's competition here
PHBI vs EOFBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, EOFBF has a market cap of 327.9M. Regarding current trading prices, PHBI is priced at $0.00, while EOFBF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas EOFBF's P/E ratio is -2.33. In terms of profitability, PHBI's ROE is +0.09%, compared to EOFBF's ROE of -1.26%. Regarding short-term risk, PHBI is more volatile compared to EOFBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check EOFBF's competition here
PHBI vs GLASF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, GLASF has a market cap of 309.9M. Regarding current trading prices, PHBI is priced at $0.00, while GLASF trades at $5.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -67.44. In terms of profitability, PHBI's ROE is +0.09%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, PHBI is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check GLASF's competition here
PHBI vs ABTI Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, ABTI has a market cap of 291.9M. Regarding current trading prices, PHBI is priced at $0.00, while ABTI trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas ABTI's P/E ratio is -20.00. In terms of profitability, PHBI's ROE is +0.09%, compared to ABTI's ROE of -0.15%. Regarding short-term risk, PHBI is more volatile compared to ABTI. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check ABTI's competition here
PHBI vs PKBFF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, PKBFF has a market cap of 289.9M. Regarding current trading prices, PHBI is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, PHBI's ROE is +0.09%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, PHBI is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check PKBFF's competition here
PHBI vs BHHKF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, BHHKF has a market cap of 287.4M. Regarding current trading prices, PHBI is priced at $0.00, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, PHBI's ROE is +0.09%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, PHBI is less volatile compared to BHHKF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check BHHKF's competition here
PHBI vs VRNOF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, VRNOF has a market cap of 259M. Regarding current trading prices, PHBI is priced at $0.00, while VRNOF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -0.72. In terms of profitability, PHBI's ROE is +0.09%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, PHBI is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check VRNOF's competition here
PHBI vs BHCCF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, BHCCF has a market cap of 243.9M. Regarding current trading prices, PHBI is priced at $0.00, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, PHBI's ROE is +0.09%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, PHBI is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check BHCCF's competition here
PHBI vs CRLBF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CRLBF has a market cap of 237.6M. Regarding current trading prices, PHBI is priced at $0.00, while CRLBF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.93. In terms of profitability, PHBI's ROE is +0.09%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, PHBI is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check CRLBF's competition here
PHBI vs CPHRF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, CPHRF has a market cap of 233.2M. Regarding current trading prices, PHBI is priced at $0.00, while CPHRF trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 25.28. In terms of profitability, PHBI's ROE is +0.09%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, PHBI is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check CPHRF's competition here
PHBI vs PSIQ Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, PHBI is priced at $0.00, while PSIQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas PSIQ's P/E ratio is N/A. In terms of profitability, PHBI's ROE is +0.09%, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, PHBI is less volatile compared to PSIQ. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check PSIQ's competition here
PHBI vs PLNHF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, PHBI is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, PHBI's ROE is +0.09%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, PHBI is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check PLNHF's competition here
PHBI vs YOURF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, YOURF has a market cap of 178.2M. Regarding current trading prices, PHBI is priced at $0.00, while YOURF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas YOURF's P/E ratio is 0.01. In terms of profitability, PHBI's ROE is +0.09%, compared to YOURF's ROE of +0.00%. Regarding short-term risk, PHBI is less volatile compared to YOURF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check YOURF's competition here
PHBI vs WLDFF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, PHBI is priced at $0.00, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas WLDFF's P/E ratio is N/A. In terms of profitability, PHBI's ROE is +0.09%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, PHBI is less volatile compared to WLDFF. This indicates potentially lower risk in terms of short-term price fluctuations for PHBI.Check WLDFF's competition here
PHBI vs PHCUF Comparison August 2025
PHBI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHBI stands at 597.3K. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, PHBI is priced at $0.00, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHBI currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, PHBI's ROE is +0.09%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, PHBI is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHBI.Check PHCUF's competition here